CVS is getting serious about generics, and has knocked off a few brand names from its PBM formulary for 2013, reported the Wall Street Journal
. The Journal
noted that the drugstore chain started eliminating high-cost prescriptions over the summer. Some of these have made their way back onto the formulary, including Lilly/BI's Tradjenta, but the drug store chain is striking Allergan's glaucoma medicine Lumigan, Pfizer's human growth hormone Genotropin and the BMS/AstraZeneca diabetes med Onglyza
, reported the WSJ
Shifting gears faster than some expected
, the Livestrong Foundation and Lance Armstrong have parted ways, reported the New York Times
. The disgraced cyclist and cancer survivor founded the Livestrong foundation in 1997. Although he resigned as chair, following the United States Anti-Doping Agency's conclusion that Armstrong was guilty of doping while competing for the Tour de France, he was still a member of the board until November 4, reported the Times
. He was stripped of his Tour titles and banned from future Olympics sports. Jeff Garvey has replaced him as chairman.